Stock 000566 HAINAN HAIYAO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hainan Haiyao Co., Ltd.

Equities

000566

CNE0000004W8

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 21/06/2024 am IST 		5-day change 1st Jan Change
3.04 CNY +0.33% Intraday chart for Hainan Haiyao Co., Ltd. -0.65% -32.74%
29/04 Hainan Haiyao Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
26/04 Hainan Haiyao Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

HAINAN HAIYAO CO., LTD. is a China-based company principally engaged in the research, development, manufacture and sale of medicines and medical instrument. The Company’s main products consist of six categories, including cephalosporin series, stomach and intestine medicines, anti-tumor medicines, cochlear implant series, bulk drugs and intermediate series. The Company distributes its products in domestic market and to overseas market, with China as its main market.

Number of employees: 2,108

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pharmaceutical Preparations
58.8 %
914 51.4 % 856 58.8 % -6.35%
Raw Materials
36.6 %
463 26.0 % 532 36.6 % +15.00%
Inter-segment Elimination
-22.8 %
-436 -24.5 % -332 -22.8 % -23.92%
Others
15.5 %
645 36.2 % 226 15.5 % -64.98%
Traditional Chinese Medicine Warehousing and Trade
11.9 %
194 10.9 % 174 11.9 % -10.31%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
97.6 %
1,677 94.3 % 1,442 97.6 % -13.98%
Foreign
2.4 %
102 5.7 % 36 2.4 % -64.59%

Managers

Managers TitleAgeSince
Jun Hong Wang CEO
 Chief Executive Officer 55 08/22/08
Rong Yi Xu DFI
 Director of Finance/CFO 53 29/21/29
Jian Min Zhang CTO
 Chief Tech/Sci/R&D Officer 46 -
Hai Feng Yin CTO
 Chief Tech/Sci/R&D Officer 52 31/23/31
Yue Xiang Zhao BRD
 Director/Board Member 56 24/20/24
Xi Cheng Liu BRD
 Director/Board Member 62 16/05/16
Xiao Su Wang IRC
 Investor Relations Contact - -
Lei Shi SEC
 Corporate Secretary 38 27/21/27
Hui Zhang PRN
 Corporate Officer/Principal 53 01/03/01

Members of the board

Members of the board TitleAgeSince
Yu Lin Wei BRD
 Director/Board Member 67 24/20/24
Xi Cheng Liu BRD
 Director/Board Member 62 16/05/16
Duo Jia Feng BRD
 Director/Board Member 66 -
Jun Hong Wang CEO
 Chief Executive Officer 55 08/22/08
Xiu Qun Hu BRD
 Director/Board Member 51 31/23/31
Chang Liu BRD
 Director/Board Member 34 01/19/01
Yue Xiang Zhao BRD
 Director/Board Member 56 24/20/24
Zeng Fu Zhang CHM
 Chairman 59 24/20/24
Jian Ping Wang CHM
 Chairman 45 08/22/08
Shu Xiong Han BRD
 Director/Board Member 39 31/23/31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,297,365,126 756,679,688 ( 58.32 %) 0 58.32 %

Shareholders

NameEquities%Valuation
Xi Cheng Liu
25.70 %
299,510,387 25.70 % 139 M ¥
Yunnan International Trust Co., Ltd.
9.200 %
107,216,412 9.200 % 50 M ¥
J.K. Life Insurance Co., Ltd.
3.458 %
40,294,844 3.458 % 19 M ¥
Jing Hu
3.092 %
36,028,600 3.092 % 17 M ¥
Xi De Yang
1.642 %
19,132,305 1.642 % 9 M ¥
Hangzhou Tongwu Investment Management LP
1.123 %
13,082,500 1.123 % 6 M ¥
Su Fen Zhang
0.8907 %
10,380,000 0.8907 % 5 M ¥
Jin Song Guo
0.7415 %
8,641,010 0.7415 % 4 M ¥
JPMorgan Chase Bank, NA (Investment Management)
0.5169 %
6,023,458 0.5169 % 3 M ¥
Gfund Management Co., Ltd.
0.2460 %
2,867,100 0.2460 % 1 M ¥
NameEquities%Valuation
Xi Cheng Liu
99.13 %
130,825,900 99.13 % 61 M ¥

Company contact information

Hainan Haiyao Co., Ltd.

192 Nanhai Avenue Xiuying District

570311, Haikou

+86 89 8363 30888

http://www.haiyao.com.cn
address Hainan Haiyao Co., Ltd.(000566)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
HAINAN HAIYAO CO., LTD. Stock Hainan Haiyao Co., Ltd.
-32.74% 543M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+51.63% 796B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+41.51% 628B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.10% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.90% 331B
ABBVIE INC. Stock AbbVie Inc.
+9.95% 301B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.66% 244B
ROCHE HOLDING AG Stock Roche Holding AG
+3.39% 228B
NOVARTIS AG Stock Novartis AG
+10.75% 214B
AMGEN INC. Stock Amgen Inc.
+6.99% 165B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 000566 Stock
  4. Company Hainan Haiyao Co., Ltd.